Current through Register Vol. 50, No. 9, September 20, 2024
Section LIII-2917 - Authorized Direct Access Users of Prescription Monitoring InformationA. The following persons may access prescription monitoring information in the same or similar manner, and for the same or similar purposes, as those persons are authorized to access similar protected health information under federal and state law and regulation: 1. persons authorized to prescribe or dispense controlled substances or drugs of concern, and their delegates, for the purpose of providing medical or pharmaceutical care for their patients, or for verifying their prescription records;2. designated representatives from the professional licensing, certification, or regulatory agencies of this state or another state charged with administrative oversight of those professionals engaged in the prescribing or dispensing of controlled substances or other drugs of concern;3. designated representatives from the Louisiana Medicaid program regarding Medicaid program recipients;4. designated representatives of the board or any vendor or contractor establishing or maintaining the prescription monitoring program;5. a medical examiner or coroner, or a delegate thereof, for the purpose of investigating an individuals death;6. a licensed substance abuse addiction counselor providing services as part of a state-licensed substance abuse or addiction treatment program;7. an epidemiologist with the Louisiana Department of Health for the purpose of assisting the board in analyzing prescription monitoring information in order to conduct public health evaluations to support public policy and education pursuant to an agreement with the board;8. prescription monitoring programs, electronic health information systems, and pharmacy information systems located in other states, territories, federal districts, and federal jurisdictions, through a secure interstate data exchange system or health information exchange system approved by the board, but only in compliance with the provisions of R.S. 40:1007(G).La. Admin. Code tit. 46, § LIII-2917
Promulgated by the Department of Health and Hospitals, Board of Pharmacy, LR 33:1347 (July 2007), amended LR 39:315 (February 2013), LR 40:1095 (June 2014), Amended by the Department of Health, Board of Pharmacy, LR 4785 (1/1/2021), Amended by the Department of Health, Board of Pharmacy, LR 47248 (2/1/2021).AUTHORITY NOTE: Promulgated in accordance with R.S. 40:1011.